205 related articles for article (PubMed ID: 34326359)
21. Generation of non-viral, transgene-free hepatocyte like cells with piggyBac transposon.
Katayama H; Yasuchika K; Miyauchi Y; Kojima H; Yamaoka R; Kawai T; Yukie Yoshitoshi E; Ogiso S; Kita S; Yasuda K; Sasaki N; Fukumitsu K; Komori J; Ishii T; Uemoto S
Sci Rep; 2017 Mar; 7():44498. PubMed ID: 28295042
[TBL] [Abstract][Full Text] [Related]
22. Generation of Human iPSCs by Episomal Reprogramming of Skin Fibroblasts and Peripheral Blood Mononuclear Cells.
Febbraro F; Chen M; Denham M
Methods Mol Biol; 2021; 2239():135-151. PubMed ID: 33226617
[TBL] [Abstract][Full Text] [Related]
23. Generation of an Induced Pluripotent Stem Cell Line with the Constitutive EGFP Reporter.
Butterfield KT; McGrath PS; Han CM; Kogut I; Bilousova G
Methods Mol Biol; 2020; 2155():11-21. PubMed ID: 32474864
[TBL] [Abstract][Full Text] [Related]
24. Integration of xeno-free single-cell cloning in CRISPR-mediated DNA editing of human iPSCs improves homogeneity and methodological efficiency of cellular disease modeling.
Namipashaki A; Pugsley K; Liu X; Abrehart K; Lim SM; Sun G; Herold MJ; Polo JM; Bellgrove MA; Hawi Z
Stem Cell Reports; 2023 Dec; 18(12):2515-2527. PubMed ID: 37977144
[TBL] [Abstract][Full Text] [Related]
25. Differential Transgene Silencing of Myeloid-Specific Promoters in the
Klatt D; Cheng E; Hoffmann D; Santilli G; Thrasher AJ; Brendel C; Schambach A
Hum Gene Ther; 2020 Feb; 31(3-4):199-210. PubMed ID: 31773990
[TBL] [Abstract][Full Text] [Related]
26. Introducing Point Mutations into Human Pluripotent Stem Cells using Seamless Genome Editing.
Wang Y; Smith AJH; Hay DC
J Vis Exp; 2020 May; (159):. PubMed ID: 32449724
[TBL] [Abstract][Full Text] [Related]
27. Simple derivation of transgene-free iPS cells by a dual recombinase approach.
Pertek A; Meier F; Irmler M; Beckers J; Skylaki S; Endele M; Wurst W; Prakash N; Kühn R
Mol Biotechnol; 2014 Aug; 56(8):697-713. PubMed ID: 24677035
[TBL] [Abstract][Full Text] [Related]
28. Induced Pluripotent Stem Cells Meet Genome Editing.
Hockemeyer D; Jaenisch R
Cell Stem Cell; 2016 May; 18(5):573-86. PubMed ID: 27152442
[TBL] [Abstract][Full Text] [Related]
29. Non-viral reprogramming of fibroblasts into induced pluripotent stem cells by Sleeping Beauty and piggyBac transposons.
Talluri TR; Kumar D; Glage S; Garrels W; Ivics Z; Debowski K; Behr R; Kues WA
Biochem Biophys Res Commun; 2014 Jul; 450(1):581-7. PubMed ID: 24928388
[TBL] [Abstract][Full Text] [Related]
30. Derivation of induced pluripotent stem cells in Japanese macaque (Macaca fuscata).
Nakai R; Ohnuki M; Kuroki K; Ito H; Hirai H; Kitajima R; Fujimoto T; Nakagawa M; Enard W; Imamura M
Sci Rep; 2018 Aug; 8(1):12187. PubMed ID: 30111816
[TBL] [Abstract][Full Text] [Related]
31. CRISPR/Cas9-Mediated Genome Editing to Generate Clonal iPSC Lines.
Sanjurjo-Soriano C; Erkilic N; Mamaeva D; Kalatzis V
Methods Mol Biol; 2022; 2454():589-606. PubMed ID: 33755901
[TBL] [Abstract][Full Text] [Related]
32. Genome-wide piggyBac transposon mediated screening reveals genes related to reprogramming.
Zhang X; Wei X; Wu Y; Wang Y; Tan C; Hu X; Li N; Capecchi MR; Wu S
Protein Cell; 2017 Feb; 8(2):134-139. PubMed ID: 27761808
[No Abstract] [Full Text] [Related]
33. Generation of induced pluripotent stem cells from human foetal fibroblasts using the Sleeping Beauty transposon gene delivery system.
Davis RP; Nemes C; Varga E; Freund C; Kosmidis G; Gkatzis K; de Jong D; Szuhai K; Dinnyés A; Mummery CL
Differentiation; 2013; 86(1-2):30-7. PubMed ID: 23933400
[TBL] [Abstract][Full Text] [Related]
34. Reprogramming rat embryonic fibroblasts into induced pluripotent stem cells using transposon vectors and their chondrogenic differentiation in vitro.
Ye J; Hong J; Ye F
Mol Med Rep; 2015 Feb; 11(2):989-94. PubMed ID: 25352256
[TBL] [Abstract][Full Text] [Related]
35. A selectable all-in-one CRISPR prime editing piggyBac transposon allows for highly efficient gene editing in human cell lines.
Eggenschwiler R; Gschwendtberger T; Felski C; Jahn C; Langer F; Sterneckert J; Hermann A; Lühmann J; Steinemann D; Haase A; Martin U; Petri S; Cantz T
Sci Rep; 2021 Nov; 11(1):22154. PubMed ID: 34773059
[TBL] [Abstract][Full Text] [Related]
36. Generation of macrophages with altered viral sensitivity from genome-edited rhesus macaque iPSCs to model human disease.
Iwamoto Y; Seki Y; Taya K; Tanaka M; Iriguchi S; Miyake Y; Nakayama EE; Miura T; Shioda T; Akari H; Takaori-Kondo A; Kaneko S
Mol Ther Methods Clin Dev; 2021 Jun; 21():262-273. PubMed ID: 33869654
[TBL] [Abstract][Full Text] [Related]
37. Rapid Generation of Human Genetic Loss-of-Function iPSC Lines by Simultaneous Reprogramming and Gene Editing.
Tidball AM; Dang LT; Glenn TW; Kilbane EG; Klarr DJ; Margolis JL; Uhler MD; Parent JM
Stem Cell Reports; 2017 Sep; 9(3):725-731. PubMed ID: 28781079
[TBL] [Abstract][Full Text] [Related]
38. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
[TBL] [Abstract][Full Text] [Related]
39. Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9.
Ben Jehuda R; Shemer Y; Binah O
Stem Cell Rev Rep; 2018 Jun; 14(3):323-336. PubMed ID: 29623532
[TBL] [Abstract][Full Text] [Related]
40. Genome Editing of Induced Pluripotent Stem Cells Using CRISPR/Cas9 Ribonucleoprotein Complexes to Model Genetic Ocular Diseases.
Getachew H; Chinchilla B; Fernandez-Godino R
Methods Mol Biol; 2022; 2549():321-334. PubMed ID: 34128206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
